AUSTIN THEISZ: Open Payments
NPI 1730968280 · FISHERS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,703 in 91 payments from 21 companies in 2025. Trend: 2023 $2,184 · 2024 $2,863 · 2025 $1,703
Food & beverage: $1,703
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 7 | $249 |
| Corcept Therapeutics | 22 | $248 |
| Xeris Pharmaceuticals, Inc. | 9 | $166 |
| Tandem Diabetes Care, Inc. | 7 | $163 |
| Lilly USA, LLC | 10 | $156 |
| Novo Nordisk Inc | 8 | $136 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Mannkind Corporation | 3 | $62 |
| Sequel Med Tech, LLC | 2 | $43 |
| BETA BIONICS, INC. | 2 | $42 |
Products named: MINIMED 780G, Korlym, t:slim X2 Insulin Pump with Control-IQ, MOUNJARO, Ozempic, GVOKE HYPOPEN, LEQVIO, RECORLEV.
Industry payments across IN — which companies pay providers there.
